透過您的圖書館登入
IP:3.135.249.23
  • 期刊
  • Ahead-of-Print

有助於減緩COVID-19病人症狀與減少住院時間的醫用高濃度氫氧氣之回顧

Review: High Concentration Medical Hydrogen/Oxygen Mixture Gas Capable to Alleviate Symptoms of COVID-19 Patients

本文正式版本已出版,請見:10.6200/TCMJ.202312_20(4).0002

摘要


2019年冠狀病毒病Coronavirus Disease 2019(COVID-19)不僅對患者的呼吸系統與肺組織造成傷害,也有機率攻擊感染者的心血管系統而引起眾多心血管併發症,更可能造成患者隱形缺氧。經由臨床試驗與研究顯示吸入高流量與高濃度氫氧混合氣(比率66%氫氣:34%氧氣)可改善COVID-19患者呼吸系統症狀與減少住院天數,並可能降低COVID-19病毒對心血管系統的衝擊。如何提供穩定、安全的高流量/高濃度氫氧混合氣供COVID-19患者於醫院、檢疫旅館、隔離中心或居家隔離使用,以降低對於醫療資源的衝擊成為一項重要課題。

並列摘要


Coronavirus disease 2019 (COVID-19) causes damage to the respiratory system and lung tissues. There is a risk that the cardiovascular system might be attacked and lead to numerous cardiovascular complications and even invisible hypoxia. Clinical trials and research have shown that inhalation of high flow rate/concentrations of hydrogen/oxygen mixture gas (66% hydrogen: 34% oxygen) can significantly improve respiratory symptoms and reduce hospitalization days and possibly its impact on the cardiovascular system. Therefore, providing stable and safe hydrogen/oxygen mixture gas for COVID-19 patients isolated in hospitals, quarantine hotels, isolation centers, or their own homes to reduce the impact on medical resources has become a critical issue.

延伸閱讀